Company Tagline
We are developing novel non-invasive technologies to improve the life of millions of patients with implanted stents
Industry Category
Business Keywords
Company Description
NIMBLE Diagnostics is at the forefront of biotechnology research, dedicated to developing innovative, non-invasive technologies that enhance the lives of millions of patients with implanted stents. Located in Barcelona, Catalonia 08916, ES (Primary address), NIMBLE Diagnostics is committed to providing solutions for early detection and management of stent-related issues.
NIMBLE Diagnostics focuses on leveraging cutting-edge microwave-based technology to monitor the functional integrity of stents. The NIMBLE system is designed to detect in-stent restenosis, thrombosis, and stent fractures, enabling timely interventions that prevent negative outcomes. This proactive approach supports medication compliance, symptom correlation with stent function, and the identification of cardiac event triggers, all before complications arise.
NIMBLE Diagnostics is poised to revolutionize patient care, transforming the management of implanted stents through advanced diagnostic capabilities. The team at NIMBLE Diagnostics is working diligently to complete comprehensive information that will further highlight their groundbreaking work and vision. We invite the manager of NIMBLE Diagnostics to create a customized and exclusive company showcase and product listing on our platform, ensuring maximum visibility and engagement.
NIMBLE Diagnostics está a la vanguardia de la investigación biotecnológica, dedicada al desarrollo de tecnologías innovadoras y no invasivas que mejoran la vida de millones de pacientes con stents implantados. Ubicada en Barcelona, Cataluña 08916, ES (dirección principal), NIMBLE Diagnostics se compromete a proporcionar soluciones para la detección temprana y el manejo de problemas relacionados con los stents.
NIMBLE Diagnostics se centra en el aprovechamiento de la tecnología de microondas de vanguardia para monitorear la integridad funcional de los stents. El sistema NIMBLE está diseñado para detectar la reestenosis intra-stent, la trombosis y las fracturas de los stents, lo que permite intervenciones oportunas que previenen resultados negativos. Este enfoque proactivo apoya el cumplimiento de la medicación, la correlación de los síntomas con la función del stent y la identificación de los desencadenantes de eventos cardíacos, todo antes de que surjan complicaciones.
NIMBLE Diagnostics está preparada para revolucionar la atención al paciente, transformando el manejo de los stents implantados a través de capacidades de diagnóstico avanzadas. El equipo de NIMBLE Diagnostics está trabajando diligentemente para completar información integral que destaque aún más su trabajo innovador y su visión. Invitamos al gerente de NIMBLE Diagnostics a crear una presentación de empresa y un listado de productos personalizados y exclusivos en nuestra plataforma, garantizando la máxima visibilidad y participación.
Key Personnel / Employees
Similar Companies
Other organizations in the same industry
Scantox Group
Biotechnology-ResearchPreclinical CRO services | Discovery, Regulatory Toxicology, Analytical | Proudly certified Great Pl...
Longevity Summit Dublin
Biotechnology-ResearchRecognising emerging research developments to extend human healthspan by gathering together world le...
Global Clinical Engineering Alliance
Biotechnology-ResearchGCEA is the only international organization uniquely dedicated to the advancement of the Clinical En...
BioPhenyx
Biotechnology-ResearchYour Truth Detector in Patient Prognostics, Drug Development and Use, Improving Success-Rates from T...
Alternative Company Names
This company is also known as